References
- PottegardASchmidtSAWallach-KildemoesHSorensenHTHallasJSchmidtMData resource profile: the Danish National Prescription RegistryInt J Epidemiol201746379827789670
- NielsenLHLokkegaardEAndreasenAHKeidingNUsing prescription registries to define continuous drug use: how to fill gaps between prescriptionsPharmacoepidemiol Drug Saf200817438438818213736
- SinnottSJPolinskiJMByrneSGagneJJMeasuring drug exposure: concordance between defined daily dose and days’ supply depended on drug classJ Clin Epidemiol20166910711326146090
- StovringHPottegardAHallasJDetermining prescription durations based on the parametric waiting time distributionPharmacoepidemiol Drug Saf201625121451145927670969
- BaysAMGardnerGPharmacologic therapies for rheumatologic and autoimmune conditionsMed Clin North Am2016100471973127235612
- LaugesenKJorgensenJOLSorensenHTPetersenISystemic glucocorticoid use in Denmark: a population-based prevalence studyBMJ Open201775e015237
- FardetLPetersenINazarethIPrevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 yearsRheumatology (Oxford)201150111982199021393338
- ButtgereitFda SilvaJABoersMStandardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatologyAnn Rheum Dis200261871872212117678
- SchmidtMPedersenLSorensenHTThe Danish Civil Registration System as a tool in epidemiologyEur J Epidemiol201429854154924965263
- WHO Collaborating Centre for Drug Statistics MethodologyDefinition and general considerations Available from: https://www.whocc.no/ddd/definition_and_general_considera/Accessed January 13, 2017